Our team has extensive collective experience and knowledge in academic research, executive and corporate management, government and international trade. The managing partners of Pacific Channel’s US-based sister company 
The Channel Group  have formed, managed and grown entrepreneurial life sciences companies for decades.

Pacific Channel

 
Brent S. Ogilvie, BSc. (Bio.), MBA | Email Brent

• Founder and Director of Pacific Channel Limited, which is a venture development and investment company specialising in technology and life science-based industries.
• Foundation CEO (Part-time) of Androgenix Limited, a biotechnology company that applies genomic technology for the development products with application in the world-wide livestock industry.
• Executive Director of Ecodiesel Limited, which has developed a proprietary manufacturing process to convert tallow (purified animal fat) into biodiesel at a capital cost several-fold lower and at a lower operating cost than known alternative processes.  
• Executive Director of Sleep Limited
• Executive Director of Ingredient Solutions Limited
• Former NZ Consul & Trade Commissioner to New York - Life Sciences
• Former Trade NZ Sector Leader – Life Sciences & Agritechnologies
• Former Product Manager of a Fletcher Challenge subsidiary
• Former Technical consultant to NZ start-ups

Mitali Purohit, BSc. (Bio.), MBE. (Hons)

• Mitali Purohit is a Research Analyst at Pacific Channel Limited
• Through Pacific Channel activities as a seed investor, Ms. Purohit serves as a Chief Operating Officer for Breathe Easy Ltd, a biotechnology company that is developing a treatment for Cystic Fibrosis
• Ms Purohit has experience in assessing investment opportunities and assisting early stage life-science and engineering based ventures to become investment ready
• Ms Purohit’s principal interest is in technology commercialization, especially opportunity analysis, marketing and business development
• Her Master’s thesis investigated ingredient co-branding as a strategy option for a New Zealand supplier of functional ingredients

The Channel Group LLC

Robert J. Beckman

• Managing Partner - The Channel Group
• Current Board Member of private and public medical companies, including EZ EM Corporation (Nasdaq: EZEM)
• Current Trustee of New York Medical College
• Founder and immediate past CEO of Intergen Company, a multinational life sciences company involved in pharmaceuticals, diagnostics, and discovery tools
• Former Vice President, Marketing Services and Vice President and General Manager of Biochemical and Diagnostic Division of Revlon Health Care
  • A founder, past Chairman and long-term Board Member of BIO (Biotechnology Industry Organisation) and the New York Biotechnology Association
• Co-Author of Bold Steps – New Horizons , an analysis and plan for advancing Biotechnology in New Zealand

Allan R. Goldberg, Ph.D.

• Managing Partner - The Channel Group
• Founder of several start-ups, including Zystor Therapeutics, Inc., which received a venture financing of approximately US $10 million where he serves as a Member of the Board of Directors
• Member of the Board of Directors of SuperGen Inc. (NasdaqNM:SUPG)
• Former Professor of Virology at the Rockefeller University
• Founder, CSO and CEO of Innovir Laboratories, Inc., a biopharmaceutical company focused on development of RNA drugs Took Innovir public on Nasdaq.
• Co-Author of Bold Steps – New Horizons, an analysis and plan for advancing Biotechnology in New Zealand

Philip N. Sussman

• Managing Partner - The Channel Group
• Member of Senior Management (Head of Business Development, CFO, and CEO) at several life sciences companies including Perlegen Sciences, Inc., Memory Pharmaceuticals Corp., and Cadus Pharmaceutical Corp.
• Took company public on Nasdaq while CFO
• Completed strategic alliances with major pharmaceutical companies including AstaZeneca AB, Bristol-Myers Squibb Co., Eli Lilly & Co., GlaxoSmithKline plc, Pfizer Inc., Solvary Pharmaceuticals B.V., and Unilever plc, transactions that provided funding in excess of US $100 million
• Director of Business Development at Ciba-Geigy Corp.’s Pharmaceuticals Division
• Advisor to PsychoGenics Inc., Automated Cell, Inc., and SCIUS Capital Group LLC